Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients

Rheumatology (Oxford). 2011 Feb;50(2):417-9. doi: 10.1093/rheumatology/keq218. Epub 2010 Aug 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Interleukin-1 / therapeutic use*
  • Macrophage Activation / drug effects*
  • Macrophage Activation Syndrome / drug therapy*
  • Male
  • Rheumatic Diseases / complications*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Interleukin-1